• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
(Z)-4-Hydroxytamoxifen

(Z)-4-Hydroxytamoxifen

Product ID H9711
Cas No. 68047-06-3
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $127.30 In stock
10 mg $212.10 In stock
25 mg $440.90 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

(Z)-4-Hydroxytamoxifen is the more active isomer of 4-hydroxytamoxifen. 4-Hydroxytamoxifen is the active metabolite of tamoxifen, a selective estrogen receptor modulator (SERM) that acts as an agonist or antagonist in various tissues. 4-Hydroxytamoxifen exhibits anticancer chemotherapeutic activity, inducing autophagy and vacuole formation as well as KRAS degradation in various cancer cell lines. In cardiac myocytes, 4-hydroxytamoxifen decreases Ca2+ amplitude, slowing relaxation and decreasing contractility.

Product Info

Cas No.

68047-06-3

Purity

≥98%

Formula

C26H29NO2

Formula Wt.

387.51

IUPAC Name

4-[(Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol

Melting Point

142-144°C

Solubility

Soluble in DMSO, ethanol (20mg/ml) or methanol (10mg/ml); insoluble water.

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

H9711 MSDS PDF

Info Sheet

H9711 Info Sheet PDF

References

Asp ML, Martindale JJ, Metzger JM. Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling. PLoS One. 2013 Oct 24;8(10):e78768. PMID: 24205315.

Kohli L, Kaza N, Coric T, et al. 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res. 2013 Jul 15;73(14):4395-405. PMID: 23722551.

Schwartz JA, Zhong L, Deighton-Collins S, et al. Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen. J Biol Chem. 2002 Apr 12;277(15):13202-9. Erratum in: J Biol Chem 2002 Jul 5;277(27):24842. PMID: 11823467.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • R3012

    Recombinant TpN 17 protein

    Recombinant protein containing Treponema pallidum ...
    ≥95%
  • G7443

    GSK-429286A

    ROCK1/2 inhibitor, potential RSK and p70S6K inhibi...
    ≥98%
  • I5212

    Indirubin

    Bisindole isomer of indigo found in Indigo natural...
    ≥98%
  • P0269

    Parathyroid Hormone (1-34), cow

    Endogenous peptide hormone, increases extracellula...
    ≥95%
  • M5776

    Motilin, pig

    Endogenous peptide hormone, involved in enteric mo...
    ≥98%
  • B5074

    BMS-599626

    EGFR, VEGFR inhibitor.
    ≥98%
  • F4400

    Flag Peptide

    Peptide, used to tag proteins for affinity chromat...
    ≥95%
  • R0272

    Rasagiline Mesylate

    MAO-A/B inhibitor.
    ≥98%
  • C4418

    Clemizole Hydrochloride

    TRPC5, NS4B, histamine H1 inhibitor.
    ≥98%
  • V0145

    Valinomycin

    Peptide, neutral ionophore.
    ≥98%
  • D1722

    Defactinib

    FAK inhibitor.
    ≥98%
  • P0013

    P7C3

    Aminopropyl carbazole, neuroprotective.
    ≥98%
  • B5871

    Bortezomib

    Proteasome inhibitor.
    ≥98%
  • D5649

    Domperidone

    D2/3 antagonist, hERG K+ channel blocker.
    ≥98%
  • V9201

    VX-11e

    ERK2 inhibitor, potential AurKA, GSK3, CDK2, FLT3,...
    ≥98%
  • A2658

    Agomelatine

    Melatonin analog; MT1/2 agonist, 5-HT2C antagonist...
    ≥98%
  • N4524

    NLG919

    Indoleamine-2,3-dioxygenase inhibitor.
    ≥98%
  • N1868

    Neratinib

    EGFR inhibitor.
    ≥98%
  • A0820

    N-Acetyl-S-(N′-benzylthiocarbamoyl)-L-cysteine

    Cysteine-ITC conjugate, BITC derivative, antioxida...
    ≥98%
  • F4681

    Flumazenil

    GABA-A antagonist.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only